BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 10504042)

  • 1. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
    MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight.
    Desser TS; Rubin DL; Muller HH; Qing F; Khodor S; Zanazzi G; Young SW; Ladd DL; Wellons JA; Kellar KE
    J Magn Reson Imaging; 1994; 4(3):467-72. PubMed ID: 8061449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
    Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
    J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B; Tofts PS; Wang SC; Pope JM
    Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.
    Sirlin CB; Vera DR; Corbeil JA; Caballero MB; Buxton RB; Mattrey RF
    Acad Radiol; 2004 Dec; 11(12):1361-9. PubMed ID: 15596374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating liposomal contrast agents for magnetic resonance imaging.
    Ayyagari AL; Zhang X; Ghaghada KB; Annapragada A; Hu X; Bellamkonda RV
    Magn Reson Med; 2006 May; 55(5):1023-9. PubMed ID: 16586449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates.
    Duarte MG; Gil MH; Peters JA; Colet JM; Elst LV; Muller RN; Geraldes CF
    Bioconjug Chem; 2001; 12(2):170-7. PubMed ID: 11312677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
    Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
    Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.